Synopsis:
The T1a group had a worse prognosis than T1b and T1c groups (p>0.05) . Our demonstrated that adjuvant hormonal therapy and hormonal therapy plus chemotherapy reduced the risk of recurrence and death from early breast cancer regardless of initial treatment.